Acclaro Medical | $23,000,000 | (May 30, 2025)
FarmQA, Inc | $4,000,000 | (May 30, 2025)
Uplinq | $10,000,000 | (May 30, 2025)
Outcomes4Me
United States
- Boston, Massachusetts
- 30/05/2025
- Unknown
- $21,000,000
Outcomes4Me uses AI and machine learning to help cancer patients navigate their care and access personalized treatment information. When patients provide their health information, our free platform offers both doctor-approved and FDA-approved guidance based on their diagnosis, as well as relevant clinical trials and genetic testing the patient should consider. We are the first digital platform to integrate with the with the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), from the not-for-profit alliance of 33 leading cancer centers. Recent accolades include: 2024 Fast Company World Changing Idea, 2024 MedTech Breakthrough Award, 2024 Inc. Regionals Northeast, 2024 Anthem Award, 2024 BuiltIn Best Place to Work, and the MassTLC Tech Top 50: CEO of the Year Award.
- Industry Wellness and Fitness Services
- Website https://outcomes4me.com/
- LinkedIn https://www.linkedin.com/company/outcomes4me/
Related People
Maya SaidFounder
United States -
Cambridge, Massachusetts
Executive with 15 years of international strategic, operational and research experience working across academia and industry within the United States, Europe, the Middle East and Asia. Leader of global cross-functional, cross-cultural teams of up to 200 individuals. Track record building businesses and leading strategic change. Recognized contributions bridging Science, Technology, and Business. Strong leadership. Trilingual in English, French, and Arabic, working knowledge of German. Specialization in healthcare. Doctor of Science.
KhiladiPro | $1,000,000 | (May 30, 2025)
LovOn | $850,000 | (May 30, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
CurifyLabs | $7,594,115 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)
Unbound(US) | $4,000,000 | (May 30, 2025)
Rime Labs | $5,500,000 | (May 30, 2025)
Vima Therapeutics | $60,000,000 | (May 30, 2025)